We implemented a small carbon footprint laboratory set up in several universities across the world. The compact exposure systems are ideal for carbon conscious laboratories. It has been proved to be useful for hard to reach or disadvantaged geopolitical areas. Replica is the first interlaboratory network with identical harmonized vaping and smoking exposure equipment. This feature is amenable for replication studies, for training harmonization and for tackling common technical issues. Because of its characteristics it has allowed our research to follow Open Science principle of inclusion, diversity among our partners and sustainable development.
Advances in communication technologies provide opportunities for conducting quality research. The Replica Zoom support is the first interactive tobacco harm reduction in vitro training platform. Born from the international interlaboratory need to communicate during Covid 19 Pandemic, this tool has been proven a success in brainstorming and solving technical laboratory issues across the globe.
Aim of the International Kick off was to harmonize protocols, perform further technical training of the partners on biological endpoints and promote dissemination of Tobacco Harm Reduction mission and research.
Dr. Rosalia Emma discussed the presentation “Inhalation preclinical assessment: In vitro science for real life user” during the panel dedicated to “Tackling concerns around industry standards”.
In early May, Dr. Rosalia Emma and Dr. Konstantinos Partsinevelos completed a four-day site visit at the University of Kragujevac, Serbia, as part of the training sessions of the Replica 2.0 project
The findings presented by CoEHAR researchers can contribute the discussions of ENDS for cessation and support harm reduction strategies in the world.
The CoEHAR Director, Professor Giovanni Li Volti, has been invited to present the results of the REPLICA project at the 24th National Congress of the Italian Society for Cardiovascular Research (SIRC)
The Leading Center has started a Research Exchange for Graduate students and postdoctoral scholars coming from LMIC academic institutions. The candidates will train for several weeks to learn new research techniques related to Tobacco Studies, find mentors and start new research collaborations.
The replica exchange program offers specialized training and research techniques that enhance the study of smoke behavior, support the development of complex simulation projects, and help guide the overall direction of dissertation research.
Chiara Giardina, a young student of the University of Catania, wins the Tobacco Harm Reduction Scholarship Programme by KAC thanks to a research project on the effects of cigarette smoke and aerosol from next-generation products coordinated by CoEHAR
📍 Warsaw, Poland
📅 June 13-15 2024
🔗 GFN 2024: Replica research hosted in Warsaw
📍 Edinburgh, United Kingdom
📅 17 - 17 October 2024
🔗 New data from the Replica Project at CORESTA 2024
CoEHAR, through the Replica Study collaboration, is expanding its activities by signing a letter of intent with the Universitas Padjadjaran in Indonesia, Replica Partner This is a significant step to promote the internationalization process of the center and a recognition of CoEHAR’s global strategic importance.
The University of Catania and the CoEHAR, the Center of excellence for the acceleration of harm reduction, are proud to host a lectio magistralis by prof. Ronny Lesmana, Associate Professor of Physiology at the Faculty of Medicine of the University of Padjadjaran, Indonesia.
Dr. Nikolina Kastratovic of the Faculty of Medical Sciences at the University of Kragujevac, Serbia, was honored with the award for her outstanding project on the immunomodulatory effects of combustible and electronic cigarettes on human cells.
The second edition of the Talent Research Program was presented at the THR Asia-Pacific Conference held in Bandung, Indonesia, on June 14, 2025. Representing Indonesia, Intan Masyfufah Hanim showcased her research titled “The Effect of Tephrosia vogelii Seed Extract on Inflammation in Human Umbilical Vein Endothelial Cells (HUVEC).” Her study explores the anti-inflammatory potential of natural plant compounds in the context of vascular health, aligning with the program's mission to promote scientific innovation in Tobacco Harm Reduction through emerging researchers in low- and middle-income countries.
2025 Asia-Pacific Conference on Smoking and Harm Reduction
📍 Bandung, Indonesia
📅 14 June 25
🔗 ASIA-PACIFIC CONFERENCE
EUROTOX Congress 2025
📍 Athens, Greece
📅 14 September 2025
🔗 Welcome – EUROTOX Congress 2025
63° SIB Congress
📍 Palermo, Italy
📅 10-12 September 2025
🔗 63° SIB Congress
